Both in Pharmaceuticals
Harmony Biosciences Holdings vs Agios Pharmaceuticals
Over the past year HRMY returned +26.0% and AGIO returned −11.5%; their daily moves had a correlation of 0.14.
HRMY +26.0% AGIO −11.5%Growth of $1, one year, split-adjusted
| Metric | HRMY | AGIO |
|---|---|---|
| Price | $37.95 | $38.15 |
| Market cap | $2.21B | $2.28B |
| Today | 0.00% | +0.30% |
| 1 month | −3.4% | +14.5% |
| 6 months | +22.2% | +36.0% |
| Year to date | +1.4% | +40.1% |
| 1 year | +26.0% | −11.5% |
| Revenue growth (YoY) | +30.3% | +259.3% |
| Gross margin | 75.8% | 93.3% |
| Net margin | 28.9% | −225.1% |
| P/E (TTM) | 12.2× | — |
| Price / sales | 2.3× | 23.2× |
| Net cash | $513.8M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 32.6% | 40.0% |
| Short % of float | 11.8% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).